Dr. Anwar S. Daud provides strategic guidance and operational oversight, leveraging his extensive expertise in pharmaceutical manufacturing and innovation. With a deep-rooted passion for research and development, Dr. Daud spearheads the creation of cutting-edge process technologies, ensuring the production of unique products at ZIMTAS Pty Ltd. His visionary leadership keeps ZIMTAS Pty Ltd. at the forefront of pharmaceutical innovation, driving the company toward continued growth and success.

Dr. Anwar S. Daud, who holds an M. Pharm and a Ph.D. in Pharmaceutical Chemistry and Pharmaceutics, co-founded ZIM Laboratories in 1989. As the Chairman and Managing Director of ZIM Laboratories Limited, he is dedicated to overseeing the company’s overall growth, ensuring that ZIM’s business aligns with its vision and values. Under his leadership, ZIM Labs has evolved into an R&D-focused pharmaceutical manufacturing company, supplying medications to over 50 countries while upholding stringent quality standards.

Mr. Zulfiquar Kamal exemplifies a steadfast commitment to financial integrity, commercial excellence, and corporate governance. With extensive experience in finance and corporate affairs, he oversees strategic financial management, commercial activities, and governance practices to ensure profitability and compliance at ZIMTAS Pty Ltd.

Mr. Kamal’s esteemed career spans over 25 years, beginning as a Director at ZIM Laboratories Limited in 1991. As a Chartered Accountant with more than three decades of experience, his financial expertise has been instrumental in instilling discipline and control within the organization, perfectly aligning with ZIM Labs’ core values. Through his longstanding dedication and acumen, Zulfiquar Kamal continues to shape the financial landscape and enhance governance practices at both ZIMTAS Pty Ltd and ZIM Laboratories Limited.

Mr. Mohit Gupta, the owner of MEDTAS, the shareholder company of ZIMTAS Pty Ltd., will be overseeing the registration and marketing of products through ZIMTAS Pty Ltd. With extensive experience in the pharmaceutical industry, Mr. Gupta is highly skilled in navigating the complex regulatory landscape, ensuring that all products meet stringent compliance requirements. His strategic vision and deep understanding of regulatory dynamics are pivotal in securing product approvals and maintaining high standards of quality.

Under his leadership, MEDTAS has consistently demonstrated a commitment to excellence, making him a valuable asset in expanding ZIMTAS Pty Ltd’s market presence in Australia and New Zealand. Mr. Gupta’s dedication to ethical practices and customer satisfaction ensures that ZIMTAS Pty Ltd’s products will meet the highest standards and effectively reach their target audiences.